A stem cell protein facilitates relapse of pediatric brain tumors
The malignant brain tumor type medulloblastoma can become resistant to therapy which can cause relapse. Researchers have discovered a certain protein that makes tumor cells resting and insensitive to radiation treatment. The research group hopes that the results could eventually lead to better treatments for children that have the highest risk to develop relapses.
Materials provided by Uppsala University. Original written by Linda Koffmar. Note: Content may be edited for style and length.
Source link aaaaa
